AI in Diagnostics: Opportunities for Transformation

The medtech industry is brimming with AI startups promising to revolutionize healthcare—but how many of those innovations are truly transformative? A panel at LSI Europe ’24 took a clear-eyed look at what it takes to move from promise to impact. The discussion, moderated by Andrew Pieprzyk of Hologic, featured Pau Rodriguez (Methinks AI), Dror Zur (Magentiq Eye), David Zakariaie (Senseye), and Gokce Gun (We Venture Capital), each bringing a distinct vantage point to the table. Together, they offered a grounded yet forward-looking perspective on how artificial intelligence is reshaping diagnostic workflows across stroke, colorectal cancer, mental health, and beyond.

Originally published here: https://tinyurl.com/nvkuhnep
AI in Diagnostics: Opportunities for Transformation The medtech industry is brimming with AI startups promising to revolutionize healthcare—but how many of those innovations are truly transformative? A panel at LSI Europe ’24 took a clear-eyed look at what it takes to move from promise to impact. The discussion, moderated by Andrew Pieprzyk of Hologic, featured Pau Rodriguez (Methinks AI), Dror Zur (Magentiq Eye), David Zakariaie (Senseye), and Gokce Gun (We Venture Capital), each bringing a distinct vantage point to the table. Together, they offered a grounded yet forward-looking perspective on how artificial intelligence is reshaping diagnostic workflows across stroke, colorectal cancer, mental health, and beyond. Originally published here: https://tinyurl.com/nvkuhnep
0 Commenti 0 condivisioni 8 Views 0 Anteprima
Sponsorizzato